TransMedics
Latest round
- Series F
Last raised
- May 2016
Total raised
- $230M
Investors
- 23
About TransMedics
TransMedics, Inc.Founded in 1998 and headquartered in Andover, US, TransMedics specializes in organ transplantation technologies. The company was founded by Waleed Hassanein, who has a background in medical technology innovation.00 mn.TransMedics specializes in the development and provision of advanced medical technologies designed for organ transplantation, specifically through its flagship product, the Organ Care System (OCS™). This FDA-approved technology is utilized for lung, heart, and liver transplants, significantly enhancing the viability of donor organs through a unique method of normothermic perfusion. By eliminating the limitations associated with cold storage, the OCS™ system allows for better management of ischemic time and distance constraints, ultimately improving clinical outcomes for transplant patients. The OCS™ Heart, which caters to both Donation After Brain Death (DBD) and Donation After Circulatory Death (DCD) donors, exemplifies the company's commitment to innovation within the transplantation sector.TransMedics generates revenue through the sale and lease of its OCS™ technology, along with accompanying clinical services tailored to maximize transplant efficiency and outcomes.25 mn. Transactions typically involve direct sales or partnerships with hospitals and transplant centers that utilize the OCS™ systems for their transplantation procedures. The company's revenue model is heavily oriented toward B2B relationships, as it collaborates closely with healthcare providers to implement its solutions effectively, establishing a critical role in the organ transplantation ecosystem. The company is focused on designing new versions of its OCS™ technology to enhance organ preservation further. Plans are in place to expand its market reach, targeting regions beyond the United States by 2025.
Who invested in TransMedics
23 investors across 9 rounds
See all investors in TransMedics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series F
May 12, 2016
Amount
$51M
Investors
Series F
May 29, 2015
Amount
$20M
Investors
Series D
Nov 7, 2012
Amount
$36M
Investors
Series B
Feb 17, 2010
Amount
$35M
Investors
Series D
Apr 2, 2007
Amount
$23M
Investors
Series C
Nov 23, 2005
Amount
$30M
Investors
Series C
Aug 3, 2005
Amount
$0.3M
Investors
Series B
Dec 22, 2003
Amount
$26M
Investors
Series B
Sep 4, 2001
Amount
$8.3M
Investors
Questions about TransMedics
Who invested in TransMedics?
TransMedics has 23 investors on record across 9 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TransMedics raised?
TransMedics has raised 9 venture rounds. Sign up free to see how much each round raised and the total.
When did TransMedics last raise money?
TransMedics's most recent round on record is a Series F, in May 2016.
What does TransMedics do?
TransMedics is a medical devices & equipment company.
Where is TransMedics headquartered?
TransMedics is headquartered in Andover, US.
Which VCs invest in companies like TransMedics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at TransMedics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series F
Raising like TransMedics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.